RUA Life Sciences plc (RUA.L) Comparison with companies in other sectors?

RUA Life Sciences plc has a share price of 62.06M. You can analyze RUA Life Sciences plc (RUA.L) competitors across different market sectors through stock heatmaps.

What are RUA.L's NET and operating margins?

RUA Life Sciences plc (RUA.L) operating margin is around -0.34, and net profit margin is approximately 0.07 as of the latest reports.

In what way does RUA.L's earnings per share (EPS) trend reflect its financial momentum?

RUA Life Sciences plc (RUA.L) EPS is 0.01 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for RUA Life Sciences plc is 12.13, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for RUA Life Sciences plc?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for RUA Life Sciences plc like P/E which is 36.53, P/B which is 0.96, and PEG which is 38.23. Compare them with sector averages to evaluate if the stock is priced fairly.

RUA Life Sciences plc

RUA.L•LSE

Healthcare

Medical - Devices

£12.13

£0.88(7.82%)

RUA Life Sciences plc (RUA.L) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$0.01

P/E Ratio

12.13

ROE

0.03%

Net Margin

0.07%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$7.52M

Shares OutstandingTotal number of shares issued

$62.06M

Book Value/ShareNet worth per share

$0.13

Revenue/ShareAnnual revenue per share

$0.05

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.01

Net MarginNet income as percentage of revenue

7.05%

Operating MarginOperating income as percentage of revenue

-34.30%

ROEReturn on shareholders' equity

2.74%

ROAReturn on total assets

2.10%

ROCEReturn on capital employed

-11.27%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.01

Cash/ShareCash and equivalents per share

$0.06

FCF YieldFree cash flow as percentage of market cap

-9.46%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for RUA.LFinancial Ratios Analysis details for RUA.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for RUA.LSector Benchmarking details for RUA.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for RUA Life Sciences plc Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of RUA Life Sciences plc. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account RUA Life Sciences plc's unique business strengths and challenges.

Key Financial Metrics for RUA Life Sciences plc

For RUA Life Sciences plc, essential financial indicators include EPS 0.01, PE 12.13, and ROE 0.03. These key ratios reveal insights into RUA Life Sciences plc's profitability, valuation, and operational health. Understanding these metrics enables you to compare RUA Life Sciences plc with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of RUA Life Sciences plc

Metrics like Net Margin 7.05% and ROA 2.10% shed light on how well RUA Life Sciences plc is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether RUA Life Sciences plc can sustain its operations and continue growing in the future.

Valuation and Market Position of RUA Life Sciences plc

Using ratios such as P/B Ratio 0.96 and PEG Ratio 38.23, investors can assess whether RUA Life Sciences plc is appropriately valued based on its financials and growth potential. These figures, combined with RUA Life Sciences plc's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for RUA Life Sciences plc

Financial health indicators, such as Debt/Equity Ratio 0.15 and Cash Flow $-0.01, provide a snapshot of RUA Life Sciences plc's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like RUA Life Sciences plc, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for RUA Life Sciences plc

Investing in RUA Life Sciences plc based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at RUA Life Sciences plc focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;